201 related articles for article (PubMed ID: 17688953)
1. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
Gonzalez-Rey E; Delgado M
Trends Pharmacol Sci; 2007 Sep; 28(9):482-91. PubMed ID: 17688953
[TBL] [Abstract][Full Text] [Related]
2. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.
Gonzalez-Rey E; Delgado M
Mol Cell Endocrinol; 2008 May; 286(1-2):135-40. PubMed ID: 17850953
[TBL] [Abstract][Full Text] [Related]
3. Keeping the balance between immune tolerance and pathogen immunity with endogenous neuropeptides.
Gonzalez-Rey E
Neuroimmunomodulation; 2010; 17(3):161-4. PubMed ID: 20134192
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptides as pleiotropic modulators of the immune response.
Souza-Moreira L; Campos-Salinas J; Caro M; Gonzalez-Rey E
Neuroendocrinology; 2011; 94(2):89-100. PubMed ID: 21734355
[TBL] [Abstract][Full Text] [Related]
5. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.
Anderson P; Delgado M
J Cell Mol Med; 2008 Oct; 12(5B):1830-47. PubMed ID: 18554314
[TBL] [Abstract][Full Text] [Related]
6. Regulation of immune tolerance by anti-inflammatory neuropeptides.
Gonzalez-Rey E; Chorny A; Delgado M
Nat Rev Immunol; 2007 Jan; 7(1):52-63. PubMed ID: 17186031
[TBL] [Abstract][Full Text] [Related]
7. Immune modulation in gastrointestinal disorders: new opportunities for therapeutic peptides?
de Jonge WJ; Greaves DR
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):741-8. PubMed ID: 19090735
[TBL] [Abstract][Full Text] [Related]
8. Cortistatin as a potential multistep therapeutic agent for inflammatory disorders.
Gonzalez-Rey E; Delgado M
Drug News Perspect; 2006 Sep; 19(7):393-9. PubMed ID: 17080202
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.
Delgado M; Ganea D
Brain Behav Immun; 2008 Nov; 22(8):1146-51. PubMed ID: 18598752
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides: keeping the balance between pathogen immunity and immune tolerance.
Gonzalez-Rey E; Ganea D; Delgado M
Curr Opin Pharmacol; 2010 Aug; 10(4):473-81. PubMed ID: 20399708
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
Ferone D; Boschetti M; Resmini E; Giusti M; Albanese V; Goglia U; Albertelli M; Vera L; Bianchi F; Minuto F
Ann N Y Acad Sci; 2006 Jun; 1069():129-44. PubMed ID: 16855140
[TBL] [Abstract][Full Text] [Related]
13. Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.
Chorny A; Gonzalez-Rey E; Varela N; Robledo G; Delgado M
Regul Pept; 2006 Nov; 137(1-2):67-74. PubMed ID: 16949684
[TBL] [Abstract][Full Text] [Related]
14. Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.
Shuttleworth S; Townsend P; Silva F; Cecil A; Hill T; Tomassi C; Rogers H; Harrison R
Prog Med Chem; 2011; 50():109-33. PubMed ID: 21315929
[No Abstract] [Full Text] [Related]
15. Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?
Celis R; Torre-Martinez G; Torre-Amione G
Curr Opin Cardiol; 2008 May; 23(3):254-60. PubMed ID: 18382215
[TBL] [Abstract][Full Text] [Related]
16. Herbal medicines for immunosuppression.
Amirghofran Z
Iran J Allergy Asthma Immunol; 2012 Jun; 11(2):111-9. PubMed ID: 22761185
[TBL] [Abstract][Full Text] [Related]
17. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders.
Pozo D; Gonzalez-Rey E; Chorny A; Anderson P; Varela N; Delgado M
Peptides; 2007 Sep; 28(9):1833-46. PubMed ID: 17521775
[TBL] [Abstract][Full Text] [Related]
18. Cortistatin as a therapeutic target in inflammation.
Rubio A; Avila J; de Lecea L
Expert Opin Ther Targets; 2007 Jan; 11(1):1-9. PubMed ID: 17150030
[TBL] [Abstract][Full Text] [Related]
19. The NPB/NPW neuropeptide system and its role in regulating energy homeostasis, pain, and emotion.
Hondo M; Ishii M; Sakurai T
Results Probl Cell Differ; 2008; 46():239-56. PubMed ID: 18204824
[TBL] [Abstract][Full Text] [Related]
20. PKC inhibitors: potential in T cell-dependent immune diseases.
Baier G; Wagner J
Curr Opin Cell Biol; 2009 Apr; 21(2):262-7. PubMed ID: 19195860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
